Contact Lens Spectrum

References

March 2020

Document #292

(p. 12) Prescribing for Presbyopia – Hyperopic Orthokeratology Use in Presbyopia
By Matthew Lampa, OD

  1. Mountford J, Ruston D, Dave T. Orthokeratology: Principles and Practice 1st Ed. Buttersworth-Heinemann Ltd. 2004 Aug 28.

(p. 13) GP Insights – GP Lenses and Giant Papillary Conjunctivitis
By Roxanna T. Potter, OD

  1. Forister JF, Forister EF, Yeung KK, et al. Prevalence of contact lens-related complications: UCLA contact lens study. Eye Contact Lens. 2009 Jul;35:176-180.
  2. Barnett M. Rethinking GPC: A new look at an old problem. Rev Cornea Cont Lens. 2015 Mar:10-13.
  3. Donshik PC. Contact lens chemistry and giant papillary conjunctivitis. Eye Contact Lens. 2003 Jan;29(1 Suppl):S37-9; discussion S57-S59, S192-S194.
  4. Alipour F, Khaheshi S, Soleimanzadeh M, Heidarzadeh S, Heydarzadeh S. Contact Lens-related Complications: A Review. J Ophthalmic Vis Res. 2017 Apr-Jun;12:193-204.
  5. Douglas JP, Lowder CY, Lazorik R, Meisler DM. Giant papillary conjunctivitis associated with rigid gas permeable contact lenses. CLAO J. 1988 Jul-Sep;14:143-147.
  6. Johns LK, McMahon JA, Barnett M. Scleral lens evaluation. In M. Barnett & L. Johns (Eds.), Contemporary scleral lenses: Theory and application (pp. 222). Lexington: Bentham Science Publishers.

(p. 15) Dry Eye Dx and Tx – Diabetes and MGD: Not a Sweet Story
By Katherine M. Mastrota, MS, OD

  1. Centers for Disease Control and Prevention. Type 2 Diabetes. Available at https://www.cdc.gov/diabetes/basics/type2.html . Accessed Jan. 18, 2020.
  2. Yu T, Han XG, Gao Y, Song AP, Dang GF. Morphological and cytological changes of meibomian glands in patients with type 2 diabetes mellitus. Int J Ophthalmol. 2019 Sep 10;12:1415-1419.
  3. Ding J, Liu Y, Sullivan DA. Effects of Insulin and High Glucose on Human Meibomian Gland Epithelial Cells. Invest Ophthalmol Vis Sci. 2015 Dec;56:7814-7820.
  4. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011 Mar 30;52:1938-1978.
  5. Sağdık HM, Ugurbas SH, Can M, et al. Tear film osmolarity in patients with diabetes mellitus. Ophthalmic Res. 2013;50(1):1-5.
  6. Parra SJP, López-Alemany A, Gené-Sampedro A. Correlation between type 2 diabetes, dry eye and Meibomian glands dysfunction. J Optom. 2019 Oct-Dec;12:256-262.

(p. 16) Contact Lens Care & Compliance – The Vastness of the Contact Lens Solution Market
By Melissa Barnett, OD

  1. Grand View Research. Contact Lens Solution Market Size, Share & Trends Analysis Report By Type (Multi-purpose, Hydrogen peroxide-based), By Volume, By Material, By Distribution Channel, By Region, And Segment Forecasts, 2019 – 2025. Report ID: GVR-4-68038-032-3. 2019 Nov.

(p. 17) Myopia Matters – Fine Tune Your Myopia Talk
By Brett O’Connor, OD

  1. Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016 May;123:1036-1042.
  2. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012 Nov;31:622-660.
  3. Wen D, Huang J, Chen H, et al. Efficacy and Acceptability of Orthokeratology for Slowing Myopic Progression in Children: A Systematic Review and Meta-Analysis. J Ophthalmol. 2015;2015:360806.
  4. Queirós A, González-Méijome JM, Jorge J, Villa-Collar C, Gutiérrez AR. Peripheral refraction in myopic patients after orthokeratology. Optom Vis Sci. 2010 May;87:323-329.
  5. Li SM, Kang MT, Wu SS. Studies using concentric ring bifocal and peripheral add multifocal contact lenses to slow myopia progression in school-aged children: a meta-analysis. Ophthalmic Physiol Opt. 2017 Jan;37:51-59.
  6. Bullimore MA. The Safety of Soft Contact Lenses in Children. Optom Vis Sci. 2017 Jun;94:638-646.
  7. Chalmers RL, Keay L, McNally J, Kern J. Multicenter case-control study of the role of lens materials and care products on the development of corneal infiltrates. Optom Vis Sci. 2012 Mar;89:316-325.
  8. Cooper J, Weibel K, Borukhov G. Use of Atropine to Slow the Progression of Myopia: A Literature Review and Guidelines for Clinical Use. Vision Development & Rehabilitation. 2018 Mar;4:12-28.
  9. Arumugam B, McBrien NA. Muscarinic antagonist control of myopia: evidence for M4 and M1 receptor-based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew. Invest Ophthalmol Vis Sci. 2012 Aug 24;53:5827-5837.
  10. Chia A, Lu QS, Tan D. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops. Ophthalmology. 2016 Feb;123:391-399.
  11. Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology. 2019 Jan;126:113-124.

(p. 52) Contact Lens Case Reports – Binocular Vision Issues in GP Lens Wearers
By Gregory W. DeNaeyer, OD

  1. Sherafat H, White JE, Pullum KW, Adams GG, Sloper JJ. Anomalies of binocular function in patients with longstanding asymmetric keratoconus. Br J Ophthalmol. 2001 Sep;85:1057-1060.
  2. Vincent SJ, Fadel D. Optical considerations for scleral contact lenses: A review. Cont Lens Anterior Eye. 2019 Dec;42:598-613.